Cover Image
Market Research Report

Europe Clinical Nutrition Market By Route of Administration By Application By Country, Industry Analysis and Forecast, 2020 - 2026

Published by KBV Research Product code 941679
Published Content info 104 Pages
Delivery time: 1-2 business days
Price
Back to Top
Europe Clinical Nutrition Market By Route of Administration By Application By Country, Industry Analysis and Forecast, 2020 - 2026
Published: May 31, 2020 Content info: 104 Pages
Description

Title:
Europe Clinical Nutrition Market By Route of Administration (Oral, Enteral and Parenteral) By Application (Cancer, Neurological Diseases, Gastrointestinal Disorders, Metabolic Disorders and Other Applications) By Country, Industry Analysis and Forecast, 2020 - 2026.

The Europe Clinical Nutrition Market would witness market growth of 6.5% CAGR during the forecast period (2020-2026).

The nutrition experts assert that vegan and vegan nutrition will be converted to the mass market as the demand for vegan convenience products increases, ideally packaged in sustainable packaging. A lifestyle focused on vegans and plant-based diet should be broadened to include the areas of sport and fitness. Use (digital) health trackers, performance supplements (such as advanced probiotics), or diagnostic tests (biomarkers, microbiomes, metabolome) increasingly allows consumers to follow their health strategies. In sports nutrition, the trend to consume fewer additional products and optimize performance through specific diets such as a ketogenic diet is noted.

Demand for dietetic treatment is growing, especially in clinics where demand is often overlooked because of limited funding. In addition, consumers are increasingly aware that investing in child nutrition education is a powerful instrument for promoting healthy habits from the very beginning. Our experts say health and fitness education moves from being focused solely on physical exercise to a more holistic approach with a similar emphasis on nutrition and awareness.

Industry players focus on growth strategy using various inorganic approaches, such as acquisition, partnership, strategic alliance, and others, to gain substantial market share and improve their portfolio. Increasing awareness about clinical nutrition has surged demand for pediatric as well as adult nutrition formulae. Industry players focus on developing a nutritional solution that can satisfy nutritional needs from pediatrics to adults.

Based on Route of Administration, the market is segmented into Oral, Enteral and Parenteral. Based on Application, the market is segmented into Cancer, Neurological Diseases, Gastrointestinal Disorders, Metabolic Disorders and Other Applications. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Abbott Laboratories, B. Braun Melsungen AG, Baxter International, Inc., Pfizer, Inc., Nestle S.A., Lonza Group AG, BASF SE, Ajinomoto Co., Inc., Perrigo Company PLC, and Hero Nutritionals, Inc.

Scope of the Study

Market Segmentation:

By Route of Administration

  • Oral
  • Enteral and
  • Parenteral

By Application

  • Cancer
  • Neurological Diseases
  • Gastrointestinal Disorders
  • Metabolic Disorders and
  • Other Applications

By Country

  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe

Companies Profiled:

  • Abbott Laboratories
  • B. Braun Melsungen AG
  • Baxter International, Inc.
  • Pfizer, Inc.
  • Nestle S.A.
  • Lonza Group AG
  • BASF SE
  • Ajinomoto Co., Inc.
  • Perrigo Company PLC
  • Hero Nutritionals, Inc.

Unique Offerings from KBV Research:

  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free
Table of Contents

Table of Contents

Chapter 1. Market Scope & Methodology

  • 1.1 Market Definition
  • 1.2 Objectives
  • 1.3 Market Scope
  • 1.4 Segmentation
    • 1.4.1 Europe Clinical Nutrition Market, by Route of Administration
    • 1.4.2 Europe Clinical Nutrition Market, by Application
    • 1.4.3 Europe Clinical Nutrition Market, by Country
  • 1.5 Methodology for the research

Chapter 2. Market Overview

  • 2.1 Introduction
    • 2.1.1 Overview
    • 2.1.2 Market Composition and Scenario
  • 2.2 Key Factors Impacting the Market
    • 2.2.1 Market Drivers
    • 2.2.2 Market Restraints

Chapter 3. Competition Analysis - Global

  • 3.1 KBV Cardinal Matrix
  • 3.2 Recent Industry Wide Strategic Developments
    • 3.2.1 Partnerships, Collaborations and Agreements
    • 3.2.2 Product Launches and Product Expansions
    • 3.2.3 Mergers & Acquisitions
    • 3.2.4 Geographical Expansions
  • 3.3 Top Winning Strategies
    • 3.3.1 Key Leading Strategies: Percentage Distribution (2016-2020)
    • 3.3.2 Key Strategic Move: (Partnerships, Collaborations, and Agreements : 2016, Jan - 2019, Dec) Leading Players
    • 3.3.3 Key Strategic Move: (Product Launches and Product Expansions : 2016, Mar - 2019, Oct) Leading Players

Chapter 4. Europe Clinical Nutrition Market by Route Of Administration

  • 4.1 Europe Oral Market by Country
  • 4.2 Europe Enteral Market by Country
  • 4.3 Europe Parenteral Market by Country

Chapter 5. Europe Clinical Nutrition Market by Application

  • 5.1 Europe Cancer Market by Country
  • 5.2 Europe Neurological Diseases Market by Country
  • 5.3 Europe Gastrointestinal Disorders Market by Country
  • 5.4 Europe Metabolic Disorders Market by Country
  • 5.5 Europe Other Applications Market by Country

Chapter 6. Europe Clinical Nutrition Market by End User

  • 6.1 Europe Adults Clinical Nutrition Market by Country
  • 6.2 Europe Pediatric Market by Country
  • 6.3 Europe Geriatric Market by Country

Chapter 7. Europe Clinical Nutrition Market by Country

  • 7.1 Germany Clinical Nutrition Market
    • 7.1.1 Germany Clinical Nutrition Market by Route Of Administration
    • 7.1.2 Germany Clinical Nutrition Market by Application
    • 7.1.3 Germany Clinical Nutrition Market by End User
  • 7.2 UK Clinical Nutrition Market
    • 7.2.1 UK Clinical Nutrition Market by Route Of Administration
    • 7.2.2 UK Clinical Nutrition Market by Application
    • 7.2.3 UK Clinical Nutrition Market by End User
  • 7.3 France Clinical Nutrition Market
    • 7.3.1 France Clinical Nutrition Market by Route Of Administration
    • 7.3.2 France Clinical Nutrition Market by Application
    • 7.3.3 France Clinical Nutrition Market by End User
  • 7.4 Russia Clinical Nutrition Market
    • 7.4.1 Russia Clinical Nutrition Market by Route Of Administration
    • 7.4.2 Russia Clinical Nutrition Market by Application
    • 7.4.3 Russia Clinical Nutrition Market by End User
  • 7.5 Spain Clinical Nutrition Market
    • 7.5.1 Spain Clinical Nutrition Market by Route Of Administration
    • 7.5.2 Spain Clinical Nutrition Market by Application
    • 7.5.3 Spain Clinical Nutrition Market by End User
  • 7.6 Italy Clinical Nutrition Market
    • 7.6.1 Italy Clinical Nutrition Market by Route Of Administration
    • 7.6.2 Italy Clinical Nutrition Market by Application
    • 7.6.3 Italy Clinical Nutrition Market by End User
  • 7.7 Rest of Europe Clinical Nutrition Market
    • 7.7.1 Rest of Europe Clinical Nutrition Market by Route Of Administration
    • 7.7.2 Rest of Europe Clinical Nutrition Market by Application
    • 7.7.3 Rest of Europe Clinical Nutrition Market by End User

Chapter 8. Company Profiles

  • 8.1 Abbott Laboratories
    • 8.1.1 Company Overview
    • 8.1.2 Financial Analysis
    • 8.1.3 Segmental and Regional Analysis
    • 8.1.4 Research & Development Expense
    • 8.1.5 Recent strategies and developments:
      • 8.1.5.1 Acquisition and Mergers:
      • 8.1.5.2 Product Launches and Product Expansions:
  • 8.2 B. Braun Melsungen AG
    • 8.2.1 Company Overview
    • 8.2.2 Financial Analysis
    • 8.2.3 Segmental Analysis
    • 8.2.4 Research & Development Expense
    • 8.2.5 Recent strategies and developments:
      • 8.2.5.1 Product Launches and Product Expansions:
      • 8.2.5.2 Partnerships, Collaborations, and Agreements:
  • 8.3 Baxter International, Inc.
    • 8.3.1 Company Overview
    • 8.3.2 Financial Analysis
    • 8.3.3 Regional Analysis
    • 8.3.4 Research & Development Expense
    • 8.3.5 Recent strategies and developments:
      • 8.3.5.1 Product Launches and Product Expansions:
  • 8.4 Pfizer, Inc.
    • 8.4.1 Company Overview
    • 8.4.2 Segmental and Regional Analysis
    • 8.4.3 Research & Development Expense
    • 8.4.4 Recent strategies and developments:
      • 8.4.4.1 Acquisition and Mergers:
  • 8.5 Nestle S.A.
    • 8.5.1 Company Overview
    • 8.5.2 Financial Analysis
    • 8.5.3 Segmental and Regional Analysis
    • 8.5.4 Research& Development Expense
    • 8.5.5 Recent strategies and developments:
      • 8.5.5.1 Partnerships, Collaborations, and Agreements:
      • 8.5.5.2 Product Launches and Product Expansions:
      • 8.5.5.3 Geographical Expansions:
  • 8.6 Lonza Group AG
    • 8.6.1 Company Overview
    • 8.6.2 Financial Analysis
    • 8.6.3 Segmental and Regional Analysis
    • 8.6.4 Research & Development Expense
    • 8.6.5 Recent strategies and developments:
      • 8.6.5.1 Partnerships, Collaborations, and Agreements:
      • 8.6.5.2 Product Launches and Product Expansions:
      • 8.6.5.3 Acquisition and Mergers:
  • 8.7 BASF SE
    • 8.7.1 Company Overview
    • 8.7.2 Financial Analysis
    • 8.7.3 Segmental and Regional Analysis
    • 8.7.4 Research & Development Expense
    • 8.7.5 Recent strategies and developments:
      • 8.7.5.1 Partnerships, Collaborations, and Agreements:
  • 8.8 Ajinomoto Co., Inc.
    • 8.8.1 Company Overview
    • 8.8.2 Financial Analysis
    • 8.8.3 Segmental & Regional Analysis
    • 8.8.4 Research & Development Expenses
    • 8.8.5 Recent strategies and developments:
      • 8.8.5.1 Partnerships, Collaborations, and Agreements:
      • 8.8.5.2 Acquisition and Mergers:
  • 8.9 Perrigo Company PLC
    • 8.9.1 Company Overview
    • 8.9.2 Financial Analysis
    • 8.9.3 Segmental and Regional Analysis
    • 8.9.4 Research & Development Expense
  • 8.1 Hero Nutritionals, Inc.
    • 8.10.1 Company Overview

LIST OF TABLES

  • TABLE 1 EUROPE CLINICAL NUTRITION MARKET, 2016 - 2019, USD MILLION
  • TABLE 2 EUROPE CLINICAL NUTRITION MARKET, 2020 - 2026, USD MILLION
  • TABLE 3 PARTNERSHIPS, COLLABORATIONS AND AGREEMENTS- CLINICAL NUTRITION MARKET
  • TABLE 4 PRODUCT LAUNCHES AND PRODUCT EXPANSIONS- CLINICAL NUTRITION MARKET
  • TABLE 5 MERGERS & ACQUISITIONS - CLINICAL NUTRITION MARKET
  • TABLE 6 GEOGRAPHICAL EXPANSIONS - CLINICAL NUTRITION MARKET
  • TABLE 7 EUROPE CLINICAL NUTRITION MARKET BY ROUTE OF ADMINISTRATION, 2016 - 2019, USD MILLION
  • TABLE 8 EUROPE CLINICAL NUTRITION MARKET BY ROUTE OF ADMINISTRATION, 2020 - 2026, USD MILLION
  • TABLE 9 EUROPE ORAL MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 10 EUROPE ORAL MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 11 EUROPE ENTERAL MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 12 EUROPE ENTERAL MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 13 EUROPE PARENTERAL MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 14 EUROPE PARENTERAL MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 15 EUROPE CLINICAL NUTRITION MARKET BY APPLICATION, 2016 - 2019, USD MILLION
  • TABLE 16 EUROPE CLINICAL NUTRITION MARKET BY APPLICATION, 2020 - 2026, USD MILLION
  • TABLE 17 EUROPE CANCER MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 18 EUROPE CANCER MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 19 EUROPE NEUROLOGICAL DISEASES MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 20 EUROPE NEUROLOGICAL DISEASES MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 21 EUROPE GASTROINTESTINAL DISORDERS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 22 EUROPE GASTROINTESTINAL DISORDERS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 23 EUROPE METABOLIC DISORDERS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 24 EUROPE METABOLIC DISORDERS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 25 EUROPE OTHER APPLICATIONS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 26 EUROPE OTHER APPLICATIONS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 27 EUROPE CLINICAL NUTRITION MARKET BY END USER, 2016 - 2019, USD MILLION
  • TABLE 28 EUROPE CLINICAL NUTRITION MARKET BY END USER, 2020 - 2026, USD MILLION
  • TABLE 29 EUROPE ADULTS CLINICAL NUTRITION MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 30 EUROPE ADULTS CLINICAL NUTRITION MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 31 EUROPE PEDIATRIC MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 32 EUROPE PEDIATRIC MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 33 EUROPE GERIATRIC MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 34 EUROPE GERIATRIC MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 35 EUROPE CLINICAL NUTRITION MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 36 EUROPE CLINICAL NUTRITION MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 37 GERMANY CLINICAL NUTRITION MARKET, 2016 - 2019, USD MILLION
  • TABLE 38 GERMANY CLINICAL NUTRITION MARKET, 2020 - 2026, USD MILLION
  • TABLE 39 GERMANY CLINICAL NUTRITION MARKET BY ROUTE OF ADMINISTRATION, 2016 - 2019, USD MILLION
  • TABLE 40 GERMANY CLINICAL NUTRITION MARKET BY ROUTE OF ADMINISTRATION, 2020 - 2026, USD MILLION
  • TABLE 41 GERMANY CLINICAL NUTRITION MARKET BY APPLICATION, 2016 - 2019, USD MILLION
  • TABLE 42 GERMANY CLINICAL NUTRITION MARKET BY APPLICATION, 2020 - 2026, USD MILLION
  • TABLE 43 GERMANY CLINICAL NUTRITION MARKET BY END USER, 2016 - 2019, USD MILLION
  • TABLE 44 GERMANY CLINICAL NUTRITION MARKET BY END USER, 2020 - 2026, USD MILLION
  • TABLE 45 UK CLINICAL NUTRITION MARKET, 2016 - 2019, USD MILLION
  • TABLE 46 UK CLINICAL NUTRITION MARKET, 2020 - 2026, USD MILLION
  • TABLE 47 UK CLINICAL NUTRITION MARKET BY ROUTE OF ADMINISTRATION, 2016 - 2019, USD MILLION
  • TABLE 48 UK CLINICAL NUTRITION MARKET BY ROUTE OF ADMINISTRATION, 2020 - 2026, USD MILLION
  • TABLE 49 UK CLINICAL NUTRITION MARKET BY APPLICATION, 2016 - 2019, USD MILLION
  • TABLE 50 UK CLINICAL NUTRITION MARKET BY APPLICATION, 2020 - 2026, USD MILLION
  • TABLE 51 UK CLINICAL NUTRITION MARKET BY END USER, 2016 - 2019, USD MILLION
  • TABLE 52 UK CLINICAL NUTRITION MARKET BY END USER, 2020 - 2026, USD MILLION
  • TABLE 53 FRANCE CLINICAL NUTRITION MARKET, 2016 - 2019, USD MILLION
  • TABLE 54 FRANCE CLINICAL NUTRITION MARKET, 2020 - 2026, USD MILLION
  • TABLE 55 FRANCE CLINICAL NUTRITION MARKET BY ROUTE OF ADMINISTRATION, 2016 - 2019, USD MILLION
  • TABLE 56 FRANCE CLINICAL NUTRITION MARKET BY ROUTE OF ADMINISTRATION, 2020 - 2026, USD MILLION
  • TABLE 57 FRANCE CLINICAL NUTRITION MARKET BY APPLICATION, 2016 - 2019, USD MILLION
  • TABLE 58 FRANCE CLINICAL NUTRITION MARKET BY APPLICATION, 2020 - 2026, USD MILLION
  • TABLE 59 FRANCE CLINICAL NUTRITION MARKET BY END USER, 2016 - 2019, USD MILLION
  • TABLE 60 FRANCE CLINICAL NUTRITION MARKET BY END USER, 2020 - 2026, USD MILLION
  • TABLE 61 RUSSIA CLINICAL NUTRITION MARKET, 2016 - 2019, USD MILLION
  • TABLE 62 RUSSIA CLINICAL NUTRITION MARKET, 2020 - 2026, USD MILLION
  • TABLE 63 RUSSIA CLINICAL NUTRITION MARKET BY ROUTE OF ADMINISTRATION, 2016 - 2019, USD MILLION
  • TABLE 64 RUSSIA CLINICAL NUTRITION MARKET BY ROUTE OF ADMINISTRATION, 2020 - 2026, USD MILLION
  • TABLE 65 RUSSIA CLINICAL NUTRITION MARKET BY APPLICATION, 2016 - 2019, USD MILLION
  • TABLE 66 RUSSIA CLINICAL NUTRITION MARKET BY APPLICATION, 2020 - 2026, USD MILLION
  • TABLE 67 RUSSIA CLINICAL NUTRITION MARKET BY END USER, 2016 - 2019, USD MILLION
  • TABLE 68 RUSSIA CLINICAL NUTRITION MARKET BY END USER, 2020 - 2026, USD MILLION
  • TABLE 69 SPAIN CLINICAL NUTRITION MARKET, 2016 - 2019, USD MILLION
  • TABLE 70 SPAIN CLINICAL NUTRITION MARKET, 2020 - 2026, USD MILLION
  • TABLE 71 SPAIN CLINICAL NUTRITION MARKET BY ROUTE OF ADMINISTRATION, 2016 - 2019, USD MILLION
  • TABLE 72 SPAIN CLINICAL NUTRITION MARKET BY ROUTE OF ADMINISTRATION, 2020 - 2026, USD MILLION
  • TABLE 73 SPAIN CLINICAL NUTRITION MARKET BY APPLICATION, 2016 - 2019, USD MILLION
  • TABLE 74 SPAIN CLINICAL NUTRITION MARKET BY APPLICATION, 2020 - 2026, USD MILLION
  • TABLE 75 SPAIN CLINICAL NUTRITION MARKET BY END USER, 2016 - 2019, USD MILLION
  • TABLE 76 SPAIN CLINICAL NUTRITION MARKET BY END USER, 2020 - 2026, USD MILLION
  • TABLE 77 ITALY CLINICAL NUTRITION MARKET, 2016 - 2019, USD MILLION
  • TABLE 78 ITALY CLINICAL NUTRITION MARKET, 2020 - 2026, USD MILLION
  • TABLE 79 ITALY CLINICAL NUTRITION MARKET BY ROUTE OF ADMINISTRATION, 2016 - 2019, USD MILLION
  • TABLE 80 ITALY CLINICAL NUTRITION MARKET BY ROUTE OF ADMINISTRATION, 2020 - 2026, USD MILLION
  • TABLE 81 ITALY CLINICAL NUTRITION MARKET BY APPLICATION, 2016 - 2019, USD MILLION
  • TABLE 82 ITALY CLINICAL NUTRITION MARKET BY APPLICATION, 2020 - 2026, USD MILLION
  • TABLE 83 ITALY CLINICAL NUTRITION MARKET BY END USER, 2016 - 2019, USD MILLION
  • TABLE 84 ITALY CLINICAL NUTRITION MARKET BY END USER, 2020 - 2026, USD MILLION
  • TABLE 85 REST OF EUROPE CLINICAL NUTRITION MARKET, 2016 - 2019, USD MILLION
  • TABLE 86 REST OF EUROPE CLINICAL NUTRITION MARKET, 2020 - 2026, USD MILLION
  • TABLE 87 REST OF EUROPE CLINICAL NUTRITION MARKET BY ROUTE OF ADMINISTRATION, 2016 - 2019, USD MILLION
  • TABLE 88 REST OF EUROPE CLINICAL NUTRITION MARKET BY ROUTE OF ADMINISTRATION, 2020 - 2026, USD MILLION
  • TABLE 89 REST OF EUROPE CLINICAL NUTRITION MARKET BY APPLICATION, 2016 - 2019, USD MILLION
  • TABLE 90 REST OF EUROPE CLINICAL NUTRITION MARKET BY APPLICATION, 2020 - 2026, USD MILLION
  • TABLE 91 REST OF EUROPE CLINICAL NUTRITION MARKET BY END USER, 2016 - 2019, USD MILLION
  • TABLE 92 REST OF EUROPE CLINICAL NUTRITION MARKET BY END USER, 2020 - 2026, USD MILLION
  • TABLE 93 KEY INFORMATION - ABBOTT LABORATORIES
  • TABLE 94 KEY INFORMATION - B. BRAUN MELSUNGEN AG
  • TABLE 95 KEY INFORMATION - BAXTER INTERNATIONAL, INC.
  • TABLE 96 KEY INFORMATION - PFIZER, INC.
  • TABLE 97 KEY INFORMATION - NESTLE S.A.
  • TABLE 98 KEY INFORMATION - LONZA GROUP AG
  • TABLE 99 KEY INFORMATION - BASF SE
  • TABLE 100 KEY INFORMATION -AJINOMOTO CO., INC.
  • TABLE 101 KEY INFORMATION - PERRIGO COMPANY PLC
  • TABLE 102 KEY INFORMATION - HERO NUTRITIONALS, INC.

LIST OF FIGURES

  • FIG 1 METHODOLOGY FOR THE RESEARCH
  • FIG 2 KBV CARDINAL MATRIX
  • FIG 3 KEY LEADING STRATEGIES: PERCENTAGE DISTRIBUTION (2016-2020)
  • FIG 4 KEY STRATEGIC MOVE: (PARTNERSHIPS, COLLABORATIONS, AND AGREEMENTS : 2016, JAN - 2019, DEC) LEADING PLAYERS
  • FIG 5 KEY STRATEGIC MOVE: (PRODUCT LAUNCHES AND PRODUCT EXPANSIONS : 2016, MAR - 2019, OCT) LEADING PLAYERS
  • FIG 6 RECENT STRATEGIES AND DEVELOPMENTS: ABBOTT LABORATORIES
  • FIG 7 RECENT STRATEGIES AND DEVELOPMENTS: B. BRAUN MELSUNGEN AG
  • FIG 8 RECENT STRATEGIES AND DEVELOPMENTS: NESTLE S.A.
  • FIG 9 RECENT STRATEGIES AND DEVELOPMENTS: LONZA GROUP AG
  • FIG 10 RECENT STRATEGIES AND DEVELOPMENTS: AJINOMOTO CO., INC.
Back to Top